These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 15491714

  • 21. Comparison of preoperative prostate specific antigen density and prostate specific antigen for predicting recurrence after radical prostatectomy: results from the search data base.
    Freedland SJ, Kane CJ, Presti JC, Terris MK, Amling CL, Dorey F, Aronson WJ.
    J Urol; 2003 Mar; 169(3):969-73. PubMed ID: 12576824
    [Abstract] [Full Text] [Related]

  • 22. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O, Eggener SE, Bianco FJ, Carver BS, Serio A, Scardino PT, Eastham JA.
    J Urol; 2007 Aug; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy.
    Blute ML, Bostwick DG, Bergstralh EJ, Slezak JM, Martin SK, Amling CL, Zincke H.
    Urology; 1997 Nov; 50(5):733-9. PubMed ID: 9372884
    [Abstract] [Full Text] [Related]

  • 29. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN, Stock RG, Parikh D, Yeghiayan P, Unger P.
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [Abstract] [Full Text] [Related]

  • 30. Prognostic factors for survival of patients with pathological Gleason score 7 prostate cancer: differences in outcome between primary Gleason grades 3 and 4.
    Lau WK, Blute ML, Bostwick DG, Weaver AL, Sebo TJ, Zincke H.
    J Urol; 2001 Nov; 166(5):1692-7. PubMed ID: 11586204
    [Abstract] [Full Text] [Related]

  • 31. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
    Maru N, Ohori M, Kattan MW, Scardino PT, Wheeler TM.
    Hum Pathol; 2001 Aug; 32(8):828-33. PubMed ID: 11521227
    [Abstract] [Full Text] [Related]

  • 32. [Current value of seminal vesicle biopsy in patients with prostate cancer and influence of radical prostatectomy in patients with seminal vesicle invasion].
    Losa CA, Fernando AB, Lázaro VA, Berlanga FF, Frago PS, López MA, Sanz MJ, Martínez PG, Sanz LA.
    Arch Esp Urol; 2006 Dec; 59(10):977-88. PubMed ID: 17283711
    [Abstract] [Full Text] [Related]

  • 33. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS, Rashid HH, Lotan Y, Khoddami SM, Shariat SF, Sagalowsky AI, McConnell JD, Roehrborn CG, Koeneman KS.
    Urol Oncol; 2007 Dec; 25(4):291-7. PubMed ID: 17628294
    [Abstract] [Full Text] [Related]

  • 34. Do younger men have better biochemical outcomes after radical prostatectomy?
    Freedland SJ, Presti JC, Kane CJ, Aronson WJ, Terris MK, Dorey F, Amling CL, SEARCH Database Study Group.
    Urology; 2004 Mar; 63(3):518-22. PubMed ID: 15028449
    [Abstract] [Full Text] [Related]

  • 35. Validity of the CAPRA score to predict biochemical recurrence-free survival after radical prostatectomy. Results from a european multicenter survey of 1,296 patients.
    May M, Knoll N, Siegsmund M, Fahlenkamp D, Vogler H, Hoschke B, Gralla O.
    J Urol; 2007 Nov; 178(5):1957-62; discussion 1962. PubMed ID: 17868719
    [Abstract] [Full Text] [Related]

  • 36. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer.
    D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Schnall M, Tomaszewski JE, Wein A.
    J Urol; 1995 Jul; 154(1):131-8. PubMed ID: 7539857
    [Abstract] [Full Text] [Related]

  • 37. Caveolin-1 expression is a predictor of recurrence-free survival in pT2N0 prostate carcinoma diagnosed in Japanese patients.
    Satoh T, Yang G, Egawa S, Addai J, Frolov A, Kuwao S, Timme TL, Baba S, Thompson TC.
    Cancer; 2003 Mar 01; 97(5):1225-33. PubMed ID: 12599229
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles.
    Johnson CW, Anastasiadis AG, McKiernan JM, Salomon L, Eaton S, Goluboff ET, Olsson CA, Benson MC.
    Urol Oncol; 2004 Mar 01; 22(2):107-11. PubMed ID: 15082006
    [Abstract] [Full Text] [Related]

  • 40. Isolated seminal vesicle invasion imparts better outcomes after radical retropubic prostatectomy for clinically localized prostate cancer: prognostic stratification of pt3b disease by nodal and margin status.
    Masterson TA, Pettus JA, Middleton RG, Stephenson RA.
    Urology; 2005 Jul 01; 66(1):152-5. PubMed ID: 15992904
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.